ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Upton Closer To Decision On Control, Centers Merger; ACCC Defeats Motion In Opposition

March 16, 1979

NCAB Approves 8 Cancer Centers As Comprehensive

October 4, 1991

In Brief: Brinkley Asks Subcommittee to Add $62.5 Million To NCI Budget for Unfunded Grants

May 11, 1979

Board Commends M.D. Anderson On 50th Year

May 17, 1991

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010

Cooperative Group Chairman Unhappy Over Exclusion From Funding at Recommended Levels

December 2, 1983